The impact of an autonomous nurse-led high-flow nasal cannula oxygen protocol on clinical outcomes of infants with bronchiolitis
- PMID: 36164265
- DOI: 10.1111/jocn.16525
The impact of an autonomous nurse-led high-flow nasal cannula oxygen protocol on clinical outcomes of infants with bronchiolitis
Abstract
Objective: To investigate the relationship of the implementation of a nurse-led high-flow nasal cannula oxygen protocol on the clinical outcomes of infants with bronchiolitis in a regional paediatric unit.
Background: Bronchiolitis is a common lower respiratory illness and is the leading cause for hospitalisation of infants globally. Standard care involves the provision of supportive measures. Historically, supplemental oxygen was provided by low-flow nasal cannula. High-flow nasal cannula oxygen has been increasingly adopted despite limited evidence of its efficacy.
Methods: This study employed non-equivalent, post-implementation only design to explore clinical outcomes of infants with bronchiolitis admitted for high-flow nasal cannula oxygen therapy. The study compared infants in the 24 months before and after the initiation of a high-flow nasal cannula protocol. The primary clinical outcome was length of stay, secondary outcomes included time on high flow, weaning time, escalation of care and time outside of physiological parameters. Implementation strategy evaluation was measured by compliance with applying the protocol, reported as episodes of variance, and duration of variance. The StaRI checklist was selected as the most appropriate reporting guideline.
Results: A total of 80 patients were admitted with bronchiolitis and received high-flow nasal cannula oxygen therapy during a 48-month period; 37 patients were prior, and 43 after, the introduction of a nurse-led high-flow nasal cannula protocol. Length of stay was significantly reduced in the post-implementation group compared to the historical control group (83.8 vs. 61.3 h). Time on high flow and weaning time was decreased in the post-implementation group compared to the control group (33.5 vs. 26.7 h and 26 vs.12.25 h, respectively); however, these did not reach statistical significance. There was varied application of the HFNC protocol.
Conclusions: The implementation of a nurse-led high-flow nasal cannula protocol was associated with a reduced length of stay.
Relevance to clinical practice: This study demonstrated that infants with bronchiolitis that were treated with a nurse-led high-flow nasal cannula (HFNC) therapy protocol had positive effects on clinical outcomes including a shorter length of stay than compared with those with physician-directed care in a regional paediatric unit. A weight-based (2 L/kg) HFNC therapy was safely administered to infants with bronchiolitis in a regional hospital paediatric ward with no paediatric intensive care unit (PICU).
Keywords: bronchiolitis; high-flow nasal cannula therapy; infants; oxygen therapy; protocol implementation.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
A two-tiered high-flow nasal cannula approach does not increase intensive care utilization and hospital length of stay in bronchiolitis.Eur J Pediatr. 2024 Sep;183(9):4133-4137. doi: 10.1007/s00431-024-05656-7. Epub 2024 Jun 26. Eur J Pediatr. 2024. PMID: 38926186 Free PMC article.
-
A pediatric high-flow nasal cannula protocol standardizes initial flow and expedites weaning.Pediatr Pulmonol. 2021 May;56(5):1189-1197. doi: 10.1002/ppul.25214. Epub 2021 Jan 11. Pediatr Pulmonol. 2021. PMID: 33295690
-
Has the introduction of high-flow nasal cannula modified the clinical characteristics and outcomes of infants with bronchiolitis admitted to pediatric intensive care units? A retrospective study.Arch Pediatr. 2021 Feb;28(2):141-146. doi: 10.1016/j.arcped.2020.11.006. Epub 2020 Dec 15. Arch Pediatr. 2021. PMID: 33334653
-
High flow nasal cannula as respiratory support in treating infant bronchiolitis: a systematic review.Eur J Pediatr. 2020 May;179(5):711-718. doi: 10.1007/s00431-020-03637-0. Epub 2020 Mar 31. Eur J Pediatr. 2020. PMID: 32232547
-
High flow nasal cannula in children: a literature review.Scand J Trauma Resusc Emerg Med. 2016 Jul 12;24:93. doi: 10.1186/s13049-016-0278-4. Scand J Trauma Resusc Emerg Med. 2016. PMID: 27405336 Free PMC article. Review.
Cited by
-
Application of the TIDieR checklist to improve the HFNC use in bronchiolitis management.Eur J Pediatr. 2024 Dec 17;184(1):87. doi: 10.1007/s00431-024-05880-1. Eur J Pediatr. 2024. PMID: 39690333
References
REFERENCES
-
- Bakel, L., Hamid, J., Ewusie, J., Liu, K., Mussa, J., Straus, S., Parkin, P., & Cohen, E. (2017). International variation in asthma and bronchiolitis guidelines. Pediatrics, 140(5), e20170092. https://doi.org/10.1542/peds.2017-0092
-
- Cunningham, S., Rodriguez, A., Adams, T., Boyd, K., Butcher, I., Enderby, B., MacLean, M., McCormick, J., Paton, J., Wee, F., Thomas, H., Riding, K., Turner, S., Williams, C., McIntosh, E., & Lewis, S. (2015). Oxygen saturation targets in infants with bronchiolitis (BIDS): A double-blind, randomised, equivalence trial. The Lancet, 386(9998), 1041-1048.
-
- Dadlez, N., Esteban-Cruciani, N., Khan, A., Shi, Y., McKenna, K., Azzarone, G., & Southern, W. (2019). Safety of high-flow nasal cannula outside the ICU for previously healthy children with bronchiolitis. Respiratory Care, 64(11), 1410-1415. https://doi.org/10.4187/respcare.06352
-
- Dafydd, C., Saunders, B., Kotecha, S., & Edwards, M. (2021). Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: Systematic review and meta-analysis. BMJ Open Respiratory Research, 8(1), e000844. https://doi.org/10.1136/bmjresp-2020-000844
-
- Dysart, K., Miller, T., Wolfson, M., & Shaffer, T. (2009). Research in high flow therapy: Mechanisms of action. Respiratory Medicine, 103(10), 1400-1405. https://doi.org/10.1016/j.rmed.2009.04.007
MeSH terms
Substances
LinkOut - more resources
Full Text Sources